DC
MRNA icon

Davenport & Co’s Moderna MRNA Stock Holding History

Davenport & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,494
Closed -$268K – 1069
2022
Q4 		$268K Buy
+1,494
New +$244K ﹤0.01% 856
2022
Q3 		– Sell
-1,782
Closed -$255K – 1017
2022
Q2 		$255K Sell
1,782
-26
-1% -$3.72K ﹤0.01% 857
2022
Q1 		$311K Buy
1,808
+854
+90% +$144K ﹤0.01% 858
2021
Q4 		$242K Sell
954
-1,852
-66% -$541K ﹤0.01% 976
2021
Q3 		$1.08M Sell
2,806
-93
-3% -$34.3K 0.01% 520
2021
Q2 		$681K Sell
2,899
-211
-7% -$37.7K 0.01% 566
2021
Q1 		$407K Buy
+3,110
New +$451K ﹤0.01% 578

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Davenport & Co's MRNA Position: Q1 2023 in Review

Davenport & Co sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,494 shares — an estimated $268K sold.

Davenport & Co first reported a position in MRNA in Q1 2021 and held it in 7 quarters. The position peaked at $1.08M in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Davenport & Co reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Davenport & Co sold 1,494 Moderna shares in Q1 2023, an estimated $268K.
  • Davenport & Co first reported a position in Moderna in Q1 2021 and held it in 7 quarters.
  • Davenport & Co's Moderna position peaked at $1.08M in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Davenport & Co's 13F filing for Q1 2023, filed 27 Apr 2023.